Chemoinformaics analysis of 2,3,4-Trimethylpentanoic acid
| Molecular Weight | 144.214 | nRot | 3 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 13 |
| Exact Molecular Weight | 144.115 | nRing | 0 |
| Solubility: LogS | -5.004 | nHRing | 0 |
| Solubility: LogP | 4.284 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 25.6327 |
| nHD | 1 | BPOL | 16.9193 |
| QED | 0.664 |
| Synth | 4.395 |
| Natural Product Likeliness | 3.017 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.652 |
| MDCK | 0.0000161 |
| BBB | 0.926 |
| PPB | 0.934066 |
| VDSS | 1.178 |
| FU | 0.0866638 |
| CYP1A2-inh | 0.127 |
| CYP1A2-sub | 0.638 |
| CYP2c19-inh | 0.229 |
| CYP2c19-sub | 0.939 |
| CYP2c9-inh | 0.315 |
| CYP2c9-sub | 0.665 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.663 |
| CYP3a4-inh | 0.103 |
| CYP3a4-sub | 0.324 |
| CL | 11.11 |
| T12 | 0.075 |
| hERG | 0.029 |
| Ames | 0.022 |
| ROA | 0.078 |
| SkinSen | 0.27 |
| Carcinogencity | 0.035 |
| EI | 0.093 |
| Respiratory | 0.937 |
| NR-Aromatase | 0.067 |
| Antiviral | No |
| Prediction | 0.940148 |